LYTIR

Insider · SEC Form 4 · 10% Owner

Coastlands Capital LP

In the 12 months to Nov 19, 2026, on the open market: bought $1.6M of KTTA, BOLT, ADIL. Filed a median of 1 business day after the trade.

Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these

Insider purchases and sales, by month (last 12 months)Insider purchases: $1.6M in total; Insider sales: $0 in total.Jun: Insider purchases $118KJul: Insider purchases $41KNov: Insider purchases $1.4MDecJanFebMarAprMayJunJulAugSepOctNov$1.4M
Insider purchases above the line: $1.6MInsider sales below: $0
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.
  1. KTTABought: Pasithea Therapeutics Corp. Nov 17, 2026 875,000 shares filed Nov 17, 2026 5,502,549 shares held indirectly after, as filed filing $411K
  2. BOLTBought: Bolt Biotherapeutics, Inc. Nov 17, 2026 20,000 shares filed Nov 17, 2026 515,510 shares held indirectly after, as filed filing $115K
  3. KTTABought: Pasithea Therapeutics Corp. Nov 16, 2026 583,083 shares filed Nov 17, 2026 4,627,549 shares held indirectly after, as filed filing $291K
  4. BOLTBought: Bolt Biotherapeutics, Inc. Nov 16, 2026 33,094 shares filed Nov 17, 2026 495,510 shares held indirectly after, as filed filing $195K
  5. KTTABought: Pasithea Therapeutics Corp. Nov 13, 2026 209,431 shares filed Nov 17, 2026 4,044,466 shares held indirectly after, as filed filing $104K
  6. BOLTBought: Bolt Biotherapeutics, Inc. Nov 9, 2026 50,000 shares filed Nov 10, 2026 462,416 shares held indirectly after, as filed filing $319K
  7. ADILBought: ADIAL PHARMACEUTICALS, INC. Jul 16, 2026 1,233 shares filed Jul 16, 2026 388,308 shares held indirectly after, as filed filing $3K
  8. ADILBought: ADIAL PHARMACEUTICALS, INC. Jul 14, 2026 2,000 shares filed Jul 16, 2026 387,075 shares held indirectly after, as filed filing $5K
  9. ADILBought: ADIAL PHARMACEUTICALS, INC. Jul 10, 2026 1,700 shares filed Jul 13, 2026 385,075 shares held indirectly after, as filed filing $5K
  10. ADILBought: ADIAL PHARMACEUTICALS, INC. Jul 9, 2026 10,053 shares filed Jul 13, 2026 383,375 shares held indirectly after, as filed filing $28K
  11. ADILBought: ADIAL PHARMACEUTICALS, INC. Jun 29, 2026 25,000 shares filed Jul 1, 2026 373,322 shares held indirectly after, as filed filing $65K
  12. KTTABought: Pasithea Therapeutics Corp. Jun 17, 2026 100,000 shares filed Jun 22, 2026 3,835,035 shares held indirectly after, as filed filing $53K

Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.

Stakes filed (13D/13G)

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Filings made under this filer's SEC CIK in the same 12 months, newest first; the figure is the percentage the filing states. Every recent 13D and 13G

  1. CAMPCoastlands Capital LP filed Nov 13, 2026 Schedule 13G/A passive issuer: CAMP4 Therapeutics Corporation filing 9.99%
  2. ELOXCoastlands Capital LP filed Nov 13, 2026 Schedule 13G/A passive issuer: Eloxx Pharmaceuticals, Inc. filing 9.99%
  3. XFORCoastlands Capital LP filed Nov 13, 2026 Schedule 13G/A passive issuer: X4 Pharmaceuticals, Inc. filing 9.99%
  4. ANTXCoastlands Capital LP filed Nov 13, 2026 Schedule 13G/A passive issuer: AN2 Therapeutics, Inc. filing 9.99%
  5. XLOCoastlands Capital LP filed Nov 13, 2026 Schedule 13G/A passive issuer: Xilio Therapeutics, Inc. filing 9.99%
  6. NERVCoastlands Capital LP filed Nov 13, 2026 Schedule 13G/A passive issuer: Minerva Neurosciences, Inc. filing 9.99%
  7. WHWKCoastlands Capital LP filed Nov 13, 2026 Schedule 13G/A passive issuer: Whitehawk Therapeutics, Inc. filing 6.19%
  8. STROCoastlands Capital LP filed Nov 9, 2026 Schedule 13G passive issuer: Sutro Biopharma, Inc. filing 5.14%
  9. BOLTCoastlands Capital LP filed Nov 6, 2026 Schedule 13G passive issuer: Bolt Biotherapeutics, Inc. filing 17.5%
  10. AZRCoastlands Capital LP filed Nov 3, 2026 Schedule 13G/A passive issuer: Azora Therapeutics, Inc. filing 4.99%
  11. Coastlands Capital LP filed Nov 2, 2026 Schedule 13G/A passive issuer: Azora Therapeutics, Inc. filing 4.99%
  12. KLRSCoastlands Capital LP filed Oct 26, 2026 Schedule 13G passive issuer: Kalaris Therapeutics, Inc. filing 5.69%
  13. FLSCCoastlands Capital LP filed Oct 16, 2026 Schedule 13G passive issuer: Frazier Life Sciences Acquisition Corp. II filing 6.41%
  14. IBIOCoastlands Capital LP filed Oct 14, 2026 Schedule 13G passive issuer: iBio, Inc. filing 9.72%
  15. OKURCoastlands Capital LP filed Oct 7, 2026 Schedule 13G passive issuer: OnKure Therapeutics, Inc. filing 6.67%
  16. PYXSCoastlands Capital LP filed Oct 5, 2026 Schedule 13G passive issuer: Pyxis Oncology, Inc. filing 5.42%
  17. ADILCoastlands Capital LP filed Jul 1, 2026 Schedule 13G/A passive issuer: ADIAL PHARMACEUTICALS, INC. filing 14.22%
  18. KTTACoastlands Capital LP filed Jul 1, 2026 Schedule 13G/A passive issuer: Pasithea Therapeutics Corp. filing 11.48%